Last update :
08/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anticoagulant   Tirofiban  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Aggrastat Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Great Britain, Hungary, Iran, Ireland, Italy, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Poland, Portugal, Saudi Arabia, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America
Agrastat Argentina, Brazil, Chile, Colombia, Ecuador, Egypt, France, Mexico, Morocco, Peru, Spain, Venezuela
Thrombostat Turkey
Tirofiban Germany, Spain
Tiroprest Turkey
Welban Spain
Xtraban India
Stability of mixtures   Injection   Stability of mixtures : Tirofiban     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Atropine sulfate 0,4 & 1 mg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Dobutamine hydrochloride 0,25 & 5 mg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Epinephrine hydrochloride 2 & 100 µg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Furosemide 0,5 & 10 mg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Midazolam hydrochloride 0,05 & 5 mg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Morphine sulfate 0,1 & 1 mg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Nitroglycerin 0,1 & 0,4 mg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Glass NaCl 0,9% or Glucose 5% 50 µg/ml
Injection   Tirofiban   
Injection   Propranolol hydrochloride 1 mg/ml
20°C-25°C
4 Hour
Light 1603
Level of evidence A+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 25 µg/ml
Injection   Tirofiban   
Injection   Dopamine hydrochloride 0.1 & 1.6 mg/ml
25°C
4 Hour
Light 1420
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 25 µg/ml
Injection   Tirofiban   
Injection   Famotidine 0.1 & 2 mg/ml
25°C
4 Hour
Light 1420
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 25 µg/ml
Injection   Tirofiban   
Injection   Lidocaine hydrochloride 0.5 & 10 mg/ml
25°C
4 Hour
Light 1420
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 25 µg/ml
Injection   Tirofiban   
Injection   Heparin sodium 20 & 50 UI/ml
25°C
4 Hour
Light 1420
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 25 µg/ml
Injection   Tirofiban   
Injection   Potassium chloride 5 & 20 mEq/l
25°C
4 Hour
Light 1420
Level of evidence C+
Not specified NaCl 0,9% or Glucose 5% 25 µg/ml
Injection   Tirofiban   
Injection   Argatroban 0,5 mg/ml
20°C-25°C
4 Hour
Not specified 2004
Not specified NaCl 0,9% or Glucose 5% 5,5 µg/ml
Injection   Tirofiban   
Injection   Argatroban 0,85 mg/ml
20°C-25°C
4 Hour
Not specified 2004
  Mentions Légales